-
Board Certification
American Board of Obstetrics & GynecologyAmerican Board of Obstetrics & Gynecology (Sub: Gynecologic Oncology)Patient Rating
4.9 /5( out of 172 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
January 09, 2025HUNTSMAN CANCER CENTERBrilliant doctor'very kind and compassionate. She was honest but not brutal.
January 03, 2025HUNTSMAN CANCER CENTERShe is great. She makes me feel welcome and I trust her.
December 31, 2024HUNTSMAN CANCER CENTERDr. Maurer is the best. She is very focussed on you as a patient and is very kind. She is very knowledgeable. Huntsman is a great team.
December 13, 2024HUNTSMAN CANCER CENTERJust amazing!!!
November 27, 2024HUNTSMAN CANCER CENTERDr Maurer embodies the definition of a professionalism. Throughout the visit, her every action was kind, attentive and knowledgeable. She was fully present in every moment, and answered every question with thoughtful well-considered insight. I feel very comfortable and relaxed to put the next steps of my care into her competent hands.
November 27, 2024HUNTSMAN CANCER CENTERDr. Maurer took the time to explain the process and answer all my questions. She explained in a simple format- I definitely recommend seeing her!
October 29, 2024HUNTSMAN CANCER CENTERDr. Maurer provides excellent medical care!
October 29, 2024HUNTSMAN CANCER CENTERDr. Maurer is amazing! Exceptional skills coupled with compassionate honesty make her a trusted surgeon.
October 22, 2024HUNTSMAN CANCER CENTEROutstanding physician in every regard. She addressed all concerns and did so thoroughly and in a way that was easily understandable. She did not make Md feel rushed. She heard my concerns - both those spoken and those not spoken. Instinctive. Smart. Well read. Up-to-date on all published peer reviewed medical & scientific literature. So much better than I could have even anticipated. I feel assured that my care will be the best it can be. In a word (or two): World class.
-
Board Certification and Academic Information
Academic Departments Obstetrics & Gynecology -Primary Academic Divisions Gynecological Oncology
Board Certification American Board of Obstetrics & GynecologyAmerican Board of Obstetrics & Gynecology (Sub: Gynecologic Oncology)Education history
Fellowship Gynecologic Oncology - Cleveland Clinic Fellow Residency Obstetrics and Gynecology - Ļć½¶ŹÓʵ of Utah School of Medicine Resident Professional Medical Medicine - Ļć½¶ŹÓʵ of Michigan Medical School M.D. Undergraduate Geology, Biology - Brown Ļć½¶ŹÓʵ Sc.B. Selected Publications
Journal Article
- Barnard ME, Farland LV, Yan B, Wang J, Trabert B, Doherty JA, Meeks HD, Madsen M, Guinto E, Collin LJ, Maurer KA, Page JM, Kiser AC, Varner MW, Allen-Brady K, Pollack AZ, Peterson KR, Peterson CM, Schliep KC (2025). Endometriosis Typology and Ovarian Cancer Risk. JAMA, 332(6), 482-489. ()
- Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson BD (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstet Gynecol, 140(5), 806-811. ()
- Straubhar AM, Parsons MW, Francis S, Gaffney D, Maurer KA (2021). Refusal of surgery and survival outcomes in endometrial cancer. Int J Gynecol Cancer, 31(9), 1236-1241. ()
- Casper AC, Parsons MW, Chipman J, Burt LM Jr, Suneja G, Maurer KA, Gaffney DK (2021). Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up. Gynecol Oncol, 162(2), 454-460. ()
- Parsons MW, Francis S, Maurer KA, Grant J, Gaffney DK (2020). Refusal of Radiation Results in Inferior Survival in Endometrial Cancer. Am J Clin Oncol, 43(6), 399-410. ()
- Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney D (2019). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? Gynecol Oncol, 156(1), 243-250. ()
- McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK (2019). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol, 156(1), 85-92. ()
- Rodriguez AC, Blanchard Z, Maurer KA, Gertz J (2019). Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions. Horm Cancer, 10(2-3), 51-63. ()
- Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL (2018). Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol, 151(3), 547-554. ()
- Maurer K, Michener C, Mahdi H, Rose PG (2016). Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions. J Gynecol Oncol, 28(4), e38. ()
Case Report
- Wei M, Maurer KA, Henry NL (2019). Ovarian remnant syndrome in an aromatase inhibitor-treated patient with BRCA2 mutation following bilateral oophorectomy. Breast J, 25(6), 1254-1256. ()
-
Clinical Trials